105 related articles for article (PubMed ID: 8485478)
1. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
Leblond V; Salehian BD; Borel C; Mapakou CP; Dombret H; Sutton L; Binet JL; Ankri A
Bone Marrow Transplant; 1993 Apr; 11(4):299-305. PubMed ID: 8485478
[TBL] [Abstract][Full Text] [Related]
2. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
[TBL] [Abstract][Full Text] [Related]
4. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
[TBL] [Abstract][Full Text] [Related]
5. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
[TBL] [Abstract][Full Text] [Related]
7. Serum elastase and antithrombin-3 in patients with acute graft-vs.-host disease after bone marrow transplantation.
Toda A; Takatsuka H; Nakajima T; Nomura K; Wakae T; Itoi H; Okada M; Misawa M; Hara H
Clin Transplant; 2005 Aug; 19(4):466-9. PubMed ID: 16008589
[TBL] [Abstract][Full Text] [Related]
8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
9. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.
Foley R; Couban S; Walker I; Greene K; Chen CS; Messner H; Gauldie J
Bone Marrow Transplant; 1998 Apr; 21(8):769-73. PubMed ID: 9603399
[TBL] [Abstract][Full Text] [Related]
10. [Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis].
Gur'eva MS; Baranov AA; Bagrakova SV; Nasonov EL; Zharikova DG
Ter Arkh; 2003; 75(5):52-6. PubMed ID: 12847899
[TBL] [Abstract][Full Text] [Related]
11. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
[TBL] [Abstract][Full Text] [Related]
12. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
Gordon B; Haire W; Kessinger A; Duggan M; Armitage J
Bone Marrow Transplant; 1991 Dec; 8(6):497-502. PubMed ID: 1790430
[TBL] [Abstract][Full Text] [Related]
13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
14. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation.
Lee CK; Gingrich RD; deMagalhaes-Silverman M; Hohl RJ; Joyce JK; Scott SD; Wen BC; Schlueter A
Biol Blood Marrow Transplant; 1999; 5(1):15-27. PubMed ID: 10232737
[TBL] [Abstract][Full Text] [Related]
18. [Activation of endothelium-dependent hemostatic factors following bone marrow transplantation].
Tsakiris DA; Marbet GA; Tichelli A; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1995 Mar; 125(9):416-9. PubMed ID: 7892569
[TBL] [Abstract][Full Text] [Related]
19. Changes in the natural anticoagulants following bone marrow transplantation.
Harper PL; Jarvis J; Jennings I; Luddington R; Marcus RE
Bone Marrow Transplant; 1990 Jan; 5(1):39-42. PubMed ID: 2137021
[TBL] [Abstract][Full Text] [Related]
20. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
